Skip to main content
. 2015 Oct 20;42(11):6579–6588. doi: 10.1118/1.4933244

FIG. 6.

FIG. 6.

Dose–volume histograms for all treatment plannings considered for all five patients. S-RSBT-45/180: serial rotating shield brachytherapy using either a 45° or a 180° azimuthal emission angle; H-RSBT-45/180: helical rotating shield brachytherapy using either a 45° or a 180° azimuthal emission angle; HR-CTV: high-risk clinical target volume.